+49 (228) 282404

Internationale Akademie für Pathologie
Deutsche Abteilung e.V.
Joseph-Schumpeter-Allee 33
53227 Bonn

289 - Prostate

Zurück

Autor

G. Kristiansen, Bonn, L. Egevad, SE-Stockholm, 2015

Anamnese-/Diagnoseliste

Anamnesen_LS289.pdf pdf-Datei, 17,48 KB
Diagnosen_LS289.pdf pdf-Datei, 3,94 KB

Fall 01
Age:
61 years
Clinical data:
PSA: 9.93 ng/ml. Suspicious DRE on the right side.
Topography:
prostate biopsy, right lobe.
Staining
H&E

Fall 02
Age:
51 years
Clinical data:
PSA highly elevated, suspicious DRE.
Topography/sample type:
TRUS-guided prostate biopsy.
Staining:
H&E

Fall 03
Age:
74 years
Clinical data:
BPH.
Topography/sample type:
TUR-P.
Staining:
H&E

Fall 04_Scans_Egevad
Age:
57 years
Clinical data:
S-PSA 2.7 ng/ml, PSA ratio 0.13. DRE: T1c.
Topography / sample type:
Transrectal 8-core biopsy.
Staining:
H&E + IHC for p63 + p504s (AMACR)

Fall 05_Scans_Egevad
Age:
57 years
Clinical data:
S-PSA 2.7 ng/ml, PSA ratio 0.13. DRE: T1c.
Topography / sample type:
Transrectal 8-core biopsy.
Staining:
H&E + IHC for p63 + p504s (AMACR)

Fall 06_Scans_Egevad
Age:
54 years
Clinical data:
S-PSA 4.1 ng/ml, PSA ratio 0.17, T1c.
Topography / sample type:
Transrectal 10-core biopsy.
Staining:
H&E

Fall 07_Scans_Egevad
Age:
80 years
Clinical data:
Micturition problems. TUR-P is performed.
Topography / sample type:
TUR-P specimen.
Staining:
H&E

Fall 08_Scans_Egevad
Age:
79 years
Clinical data:
S-PSA 9.3 ng/ml, PSA ratio 0.30. No palpable lesion.
Topography / sample type:
Transrectal 8-core biopsy.
Staining:
H&E

Fall 09a
Age:
61 years
Suspicious for prostate cancer
Topography/sample type:
TRUS-guided prostate biopsy
Staining:
a) H&E

Fall 09b_AMACR-p63
Age:
61 years
Suspicious for prostate cancer
Topography/sample type:
TRUS-guided prostate biopsy
Staining:
b) AMACR (Alpha-methylacyl-CoA racemase)-p63

Fall 10a
Age:
57 years
Clinical data:
PSA 1.8 ng/ml, DRE: non suspicious, prostate enlarged.
Topography/sample type:
TUR-P
Staining:
a) H&E

Fall 10b_AMACR-p63
Age:
57 years
Clinical data:
PSA 1.8 ng/ml, DRE: non suspicious, prostate enlarged.
Topography/sample type:
TUR-P
Staining:
b) p63/AMACR

Fall 11
Age:
67 years
Clinical data:
PSA 7.71 ng/l, prostate volume: 40 ml, suspicious biopsy
Topography/sample typ:
Transrectal ultrasound guided Prostate biopsy (TRUS-PB)
Staining:
H&E

Fall 12a
Age:
60 years
Clinical data:
PSA 2.3 ng/ml, DRE: non suspicious, prostate enlarged, prostate volume 83
ml. LUTS (lower urinary tract symptoms).
Topography/sample type:
TUR-P
Staining:
a) H&E

Fall 12b_AMACR-p63
Age:
60 years
Clinical data:
PSA 2.3 ng/ml, DRE: non suspicious, prostate enlarged, prostate volume 83
ml. LUTS (lower urinary tract symptoms).
Topography/sample type:
TUR-P
Staining:
b) AMACR -p63

Fall 13a
Age:
63 years
Clinical data:
PSA 4.98 ng/ml, prostate volume 49 ml, DRE non suspicious
Topography / sample type:
transrectal prostate biopsy (TRUS-PB)
Staining:
a) H&E

Fall 13b_CK5-6
Age:
63 years
Clinical data:
PSA 4.98 ng/ml, prostate volume 49 ml, DRE non suspicious
Topography / sample type:
transrectal prostate biopsy (TRUS-PB)
Staining:
b) CK5/6

Fall 14
Age:
72 years
Clinical data:
Suspicious for prostate carcinoma
Topography / sample type:
Prostate biopsy
Staining:
H&E

Fall 15
Age:
71 years
Clinical data:
PSA 5.34 ng/ml, DRE: non suspicious, prostate volume 45 ml.
Topography/sample type:
TRUS-PB
Staining:
H&E

Fall 16a
Age:
60 years
Clinical data:
PSA 2.03 ng/ml, DRE non suspicious, prostate volume 82 ml. Dysuria.
Topography/sample type:
TUR-P
Staining:
a) H&E

Fall 16b_AMACR-p63
Age:
60 years
Clinical data:
PSA 2.03 ng/ml, DRE non suspicious, prostate volume 82 ml. Dysuria.
Topography/sample type:
TUR-P
Staining:
b) AMACR-p63

Fall 17a
Age:
63 years
Clinical data:
PSA 3.2 ng/ml, prostate volume 40 ml, DRE: non suspicious
Topography/sample type:
Transrectal Prostate biopsy
Staining:
a) H&E

Fall 17b_PIN4
Age:
63 years
Clinical data:
PSA 3.2 ng/ml, prostate volume 40 ml, DRE: non suspicious
Topography/sample type:
Transrectal Prostate biopsy
Staining:
b) PIN4 (p63, Cytokeratin 5 & 14 (HMW), p504S (AMACR)

Fall 18a
Age:
67 years
Clinical data:
PSA 5 ng/ml
Topography / sample type:
Transrectal prostate biopsy (TRUS-PB)
Staining:
a) H&E

Fall 18b_PIN4
Age:
67 years
Clinical data:
PSA 5 ng/ml
Topography / sample type:
Transrectal prostate biopsy (TRUS-PB)
Staining:
b) PIN4

Fall 19
Age:
70 years
Clinical Data:
PSA 3,29 ng/ml, prostate volume 29 ml
Topography / sample type:
TRUS-guided prostate biopsy
Staining:
H&E

Fall 20
Age:
51 years
Clinical Data:
PSA: 4,6 ng/ml, prostate volume 35 ml
Topography / sample type:
Prostate biopsy
Staining:
H&E

Fall 21
Age:
88 years
Clinical data:
TUR-P
Topography / sample type:
TUR-P.
Staining:
H&E.

Fall 22
Age:
84 years
Clinical Data:
Obstructive voiding dysfunction.
Topography / sample type:
TUR-P.
Staining:
H&E

Fall 23
Age:
69 years
Clinical Data:
PSA: 117 ng/ml. positive DRE, prostate volume 33 ml
Topography / sample type:
Prostate biopsy
Staining:
H&E

Fall 24
Age:
63 years
Clinical Data:
serum PSA elevation.
Topography / sample type:
Prostate biopsy
Staining:
H&E

Fall 25
Age:
41 years
Clinical Data:
PSA: 3.4 ng/ml. DRE: negative. Prostate volume 23 ml.
Topography / sample type:
Prostate biopsy
Staining:
H&E

Fall 26
Age:
73 years
Clinical data:
PSA 5.7 ng/ml, prostate volume 67 ml, DRE suspicious for carcinoma
Topography / sample type:
TRUS-guided prostate biopsy
Staining:
H&E

Fall 27
Age:
83 years
Clinical data:
BPH
Topography / sample type:
TUR-P
Staining:
H&E

Fall 28
Age:
65 years
Clinical data:
PSA preoperatively 5.2 ng/ml
Topography / sample type:
Robotic assisted RPE.
Staining:
H&E

Powered by Smart In Media